IP Library › Assignment 035353/0836
Patent Assignment
Reel/Frame 035353/0836

Release of Security Interest

Recorded: 2015-04-01 Pages: 7
Assignor
JEFFERIES FINANCE LLC
Executed: 2015-04-01
Assignee
SANTARUS, INC.
3611 VALLEY CENTRE DRIVE, SUITE 400, SAN DIEGO, CALIFORNIA, 92130
Covered Properties (19)
A Novel Formulation , Omeprazole Antacid Complex-Immediate Release for Rapid and Sustained Suppression of Gastric Acid
Pharmaceutical Compositions for Inhibiting Acid Secretion
Pharmaceutical Formulation and Method for Treating Acid-Caused Gastrointestinal Disorders
Combination of Proton Pump Inhibitor, Buffering Agent, and Nonsteroidal Anti-Inflammatory Drug
A Novel Formulation, Omeprazole Antacid Complex-Immediate Release for Rapid and Sustained Suppression of Gastric Acid
Combination of Proton Pump Inhibitor, Buffering Agent, and Prokinetic Agent
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Novel Formulations of Proton Pump Inhibitors and Methods of Using These Formulations
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
Application: 10/938,766 →
Publication: US 2005/0220870
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Patent: 8,906,940 →
Application: 11/138,763 →
Publication: US 2005/0266071
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Patent: 8,815,916 →
Application: 11/287,888 →
Publication: US 2006/0147522
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Patent: 8,993,599 →
Application: 11/338,608 →
Publication: US 2006/0204585
Novel Formulations of Proton Pump Inhibitors and Methods of Using These Formulations
Application: 11/868,388 →
Publication: US 2009/0092658
Pharmaceutical Formulation And Method For Treating Acid-Caused Gastrointestinal Disorders
Application: 12/847,938 →
Publication: US 2010/0297220
Method for Treating Intestinal Diseases Presenting at Least One Inflammatory Component
Application: 13/766,167 →
Publication: US 2013/0209559
Antibody Formulations
Application: 13/766,966 →
Publication: US 2013/0216556
Method for Treating Intestinal Diseases Presenting at Least One Inflammatory Component
Application: 13/857,295 →
Publication: US 2013/0225537
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Jan 2, 2014
From: SANTARUS, INC.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 031910/0545 →
Security Agreement Apr 2, 2015
From: GLYCYX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 035364/0396 →
Security Interest Jul 19, 2017
From: SANTARUS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0913 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Security Interest Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
U.S. Patent Security Agreement Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. Patent Security Agreement Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073654/0242 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →